Novocure announced that the State of Israel Ministry of Health has added Optune in combination with temozolomide to the Israeli medical services basket for the treatment of patients with newly diagnosed glioblastoma. The medical services basket includes the entire range of services, medications and devices that the insured public in Israel is entitled to receive under the National Health Insurance Law.